Product Recalls in Arizona

Product recalls affecting Arizona — including food, drugs, consumer products, medical devices, and vehicles distributed to Arizona. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,798 recalls have been distributed to Arizona in the last 12 months.

52,339 total recalls
2,798 in last 12 months

Showing 741760 of 13,449 recalls

DrugDecember 30, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg Recalled by Rising Pharma Holding, Inc. Due...

The Issue: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 30, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP 20 mg Recalled by Rising Pharma...

The Issue: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 27, 2024· Eugia US LLC

Recalled Item: Progesterone Injection USP Recalled by Eugia US LLC Due to Presence of...

The Issue: Presence of Particulate Matter: A market complaint was received of a glass...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2024· Astellas Pharma US Inc.

Recalled Item: Prograf (tacrolimus) capsules Recalled by Astellas Pharma US Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 23, 2024· Astellas Pharma US Inc.

Recalled Item: Astagraf XL (tacrolimus extended-release capsules) 0.5 mg Recalled by...

The Issue: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 23, 2024· First Aid Beauty Ltd

Recalled Item: First Aid Beauty Ultra Repair Cream Recalled by First Aid Beauty Ltd Due to...

The Issue: CGMP Deviations; product intended for quarantine was inadvertently distributed

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2024· Viatris Inc

Recalled Item: Cardura XL (doxazosin) extended release tablets 8 mg Recalled by Viatris Inc...

The Issue: Failed Impurities/Degradation Specifications: Out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2024· Viatris Inc

Recalled Item: Cardura XL (doxazosin) extended release tablets 4 mg Recalled by Viatris Inc...

The Issue: Failed Impurities/Degradation Specifications: Out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2024· ENDO USA, Inc.

Recalled Item: Adrenalin Chloride Solution (Epinephrine Nasal Solution Recalled by ENDO...

The Issue: Labeling: Not Elsewhere Classified: misleading label similar in appearance...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 19, 2024· West-Ward Columbus Inc

Recalled Item: Methadone Hydrochloride Tablets Recalled by West-Ward Columbus Inc Due to...

The Issue: Failed Tablet/Capsule Specifications: Illegible product identification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 19, 2024· Hikma Injectables USA Inc

Recalled Item: ketamine inj 50 mg per 1 mL Recalled by Hikma Injectables USA Inc Due to...

The Issue: Lack of Assurance of Sterility: The tamper-evident seal on several of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 19, 2024· Hikma Injectables USA Inc

Recalled Item: phenylephrine in 0.9% Sodium Chloride Inj Recalled by Hikma Injectables USA...

The Issue: Lack of Assurance of Sterility: The tamper-evident seal on several of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 18, 2024· Alcon Research LLC

Recalled Item: Systane Lubricant Eye Drops Recalled by Alcon Research LLC Due to Non-Sterility

The Issue: Non-Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 18, 2024· Granules Pharmaceuticals Inc.

Recalled Item: Colchicine Capsules 0.6 mg Recalled by Granules Pharmaceuticals Inc. Due to...

The Issue: Failed Dissolution Specifications: Out of specification observed during the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 18, 2024· Eugia US LLC

Recalled Item: medroxyPROGESTERone Acetate Injectable Suspension Recalled by Eugia US LLC...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 18, 2024· AvKARE

Recalled Item: Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing...

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 18, 2024· AvKARE

Recalled Item: Polyvinyl Alcohol Ophthalmic Solution 1.4% Recalled by AvKARE Due to...

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 17, 2024· Amerisource Health Services LLC

Recalled Item: glipiZIDE Recalled by Amerisource Health Services LLC Due to Failed...

The Issue: Failed Dissolution Specifications:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2024· SHOPPERS- PLAZA

Recalled Item: FOUZEE SugarLin HERBAL FORMULA capsules Recalled by SHOPPERS- PLAZA Due to...

The Issue: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 16, 2024· FDC Limited

Recalled Item: Ciprofloxacin Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective container: Unable to get the solution out of the bottle as the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund